Accéder au contenu
Merck

A necroptotic-independent function of MLKL in regulating endothelial cell adhesion molecule expression.

Cell death & disease (2020-04-26)
Jialin Dai, Chonghe Zhang, Lin Guo, Hao He, Kai Jiang, Yingying Huang, Xixi Zhang, Haibing Zhang, Wu Wei, Yaoyang Zhang, Lihua Lu, Junhao Hu
RÉSUMÉ

Mixed-lineage kinase domain-like protein (MLKL) is known as the terminal executor of necroptosis. However, its function outside of necroptosis is still not clear. Herein, we demonstrate that MLKL promotes vascular inflammation by regulating the expression of adhesion molecules ICAM1, VCAM1, and E-selectin in endothelial cells (EC). MLKL deficiency suppresses the expression of these adhesion molecules, thereby reducing EC-leukocyte interaction in vitro and in vivo. Mechanistically, we show that MLKL interacts with RBM6 to promote the mRNA stability of adhesion molecules. In conclusion, this study identified a novel role of MLKL in regulating endothelial adhesion molecule expression and local EC-leukocyte interaction during acute inflammation.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Réactifs de détection in situ Duolink® Red
Sigma-Aldrich
Sonde PLA® PLUS anti-lapin in situ Duolink®, Affinity purified Donkey anti-Rabbit IgG (H+L)
Sigma-Aldrich
Sonde PLA® in situ DuolinkDuolink® anti-souris MINUS, Affinity purified Donkey anti-Mouse IgG (H+L)
Sigma-Aldrich
Iodure de propidium, ≥94.0% (HPLC)
Sigma-Aldrich
MLKL Inhibitor, Necrosulfonamide, MLKL Inhibitor, Necrosulfonamide, CAS 432531-71-0, is a cell-permeable inhibitor that covalently modifies Cys88 and blocks human MLKL adaptor function.